Cancer Therapy
New cancer therapy study results from R. Sciuto et al described
Published in Drug Law Weekly, October 6th, 2009
New research, 'Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution,' is the subject of a report. According to a study from Rome, Italy, "The study evaluates clinical presentation and outcome of differentiated thyroid cancer (DTC) on a large series of patients homogeneously managed. A cohort of 1503 DTC followed according to a standardized protocol entered the study."
"Main outcome measures were clinical presentation at the diagnosis, survival, morbidity and prognostic risk factors. Median age at diagnosis was 46 years. Papillary cancer and low pathological...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-10-06)
More Articles from Drug Law Weekly
- Autism
Autism Spectrum Therapies Co-Founder and Chief Clinical Officer Dr. William Frea Appointed to Board of Directors of Los Angeles Chapter of Autism Speaks - BioAlliance Pharma
BioAlliance Pharma Announces That the Civil Action Filed by Eurofins in the United States is Rejected - Biopharmaceuticals
DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors - Breast Cancer
U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014 - Bureau of Alcohol, Tobacco, Firearms and Explosives
Violent Offender Sentenced to 480 Months in a Federal Penitentiary for Using a Firearm to Commit a Crime of Violence, Bank Robbery and Carjacking - Flamel Technologies, S.A.
Flamel Technologies to Present at UBS Global Life Sciences Conference - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
